Cargando…
Modification of a novel angiogenic peptide, AG30, for the development of novel therapeutic agents
We previously identified a novel angiogenic peptide, AG30, with antibacterial effects that could serve as a foundation molecule for the design of wound-healing drugs. Toward clinical application, in this study we have developed a modified version of the AG30 peptide characterized by improved antibac...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823230/ https://www.ncbi.nlm.nih.gov/pubmed/21812915 http://dx.doi.org/10.1111/j.1582-4934.2011.01406.x |